Formosa Pharmaceuticals, Inc. (TPE:6838)
34.70
+0.55 (1.61%)
At close: Jun 10, 2025
Formosa Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -222.29 | -201.01 | -321.96 | -406.27 | -400.88 | -219.66 | Upgrade
|
Depreciation & Amortization | 41.9 | 41.87 | 40.3 | 39.15 | 37.63 | 36.03 | Upgrade
|
Other Amortization | 0.9 | 0.41 | 0.24 | 0.25 | 0.1 | 0.04 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | 0.2 | 0.72 | Upgrade
|
Stock-Based Compensation | 35.85 | 36.2 | 2.42 | 2.59 | - | 7.95 | Upgrade
|
Provision & Write-off of Bad Debts | 7.82 | 7.82 | - | - | - | - | Upgrade
|
Other Operating Activities | -5.09 | 25.08 | 55.09 | -0.39 | 38.79 | -0.49 | Upgrade
|
Change in Accounts Receivable | 51.53 | -12.56 | -31.45 | -0.03 | - | 0 | Upgrade
|
Change in Inventory | -1.92 | -2.89 | - | - | - | - | Upgrade
|
Change in Accounts Payable | -54.32 | 53.39 | 24.52 | 26.29 | 6.11 | -3.75 | Upgrade
|
Change in Unearned Revenue | -15 | -77.01 | 41.1 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 8.75 | 0.01 | -6.31 | -7.73 | -13.07 | -2.67 | Upgrade
|
Operating Cash Flow | -151.87 | -128.68 | -196.04 | -346.15 | -331.13 | -175.75 | Upgrade
|
Capital Expenditures | -16.12 | -7.27 | -2.17 | - | -0.22 | -4.66 | Upgrade
|
Cash Acquisitions | -79.29 | -79.29 | - | -29.87 | -71.03 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.98 | -0.98 | -0.08 | - | -14.85 | - | Upgrade
|
Investment in Securities | -465.22 | -387.27 | -673.98 | -158.75 | - | - | Upgrade
|
Other Investing Activities | -0.49 | -0.49 | 0.02 | -0.02 | - | -0.01 | Upgrade
|
Investing Cash Flow | -562.1 | -475.29 | -676.21 | -188.64 | -86.1 | -4.67 | Upgrade
|
Long-Term Debt Repaid | - | -6.05 | -4.62 | -3.07 | -3.03 | -2.98 | Upgrade
|
Net Debt Issued (Repaid) | -5.96 | -6.05 | -4.62 | -3.07 | -3.03 | -2.98 | Upgrade
|
Issuance of Common Stock | 630.45 | 630.45 | 1,005 | 503.54 | 608 | 161.43 | Upgrade
|
Other Financing Activities | - | - | - | 58.39 | - | - | Upgrade
|
Financing Cash Flow | 624.49 | 624.4 | 999.88 | 558.86 | 604.97 | 158.45 | Upgrade
|
Foreign Exchange Rate Adjustments | 44.77 | 20.65 | -10.26 | 34.35 | -20.68 | -13.44 | Upgrade
|
Net Cash Flow | -44.71 | 41.08 | 117.37 | 58.42 | 167.05 | -35.41 | Upgrade
|
Free Cash Flow | -167.99 | -135.95 | -198.21 | -346.15 | -331.35 | -180.4 | Upgrade
|
Free Cash Flow Margin | -1040.19% | -94.83% | -635.85% | -26323.19% | -1161.46% | - | Upgrade
|
Free Cash Flow Per Share | -1.16 | -0.96 | -1.60 | -3.29 | -3.58 | -2.56 | Upgrade
|
Cash Interest Paid | 0.55 | 0.57 | 0.76 | 0.99 | 0.08 | 0.1 | Upgrade
|
Cash Income Tax Paid | 0.88 | 0.88 | 3.13 | 0.07 | 2.89 | - | Upgrade
|
Levered Free Cash Flow | -106.6 | -109.71 | 9.74 | -156.49 | -255.47 | -80.85 | Upgrade
|
Unlevered Free Cash Flow | -106.25 | -109.35 | 12.43 | -155.87 | -254.09 | -80.79 | Upgrade
|
Change in Net Working Capital | 27.84 | 69.81 | -148.62 | -40.69 | 39.23 | -25.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.